Alzamend Neuro (ALZN) has provided an update.
On July 12, 2024, the Company announced a Reverse Stock Split, highlighting that this move is not an admission of the importance of the disclosed information, nor is it filed for certain legal purposes. However, the accompanying forward-looking statements, which speculate on future results and use phrases like “expects” and “will,” are meant to aid investors in making informed decisions, despite the inherent risks and uncertainties that could cause future outcomes to differ from current predictions.
See more insights into ALZN stock on TipRanks’ Stock Analysis page.
